Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo

被引:15
|
作者
Xie, Qi [1 ]
Wu, Min-Yi [1 ]
Zhang, Ding-Xuan [1 ]
Yang, Yi-Ming [1 ]
Wang, Bao-Shuai [1 ]
Zhang, Jing [2 ]
Xu, Jin [3 ]
Zhong, Wei-De [4 ]
Hu, Jia-Ni [5 ]
机构
[1] Guangzhou Med Univ, Dept Med Imaging, Nansha Cent Hosp, Guangzhou Peoples Hosp 1, Guangzhou 511457, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510080, Guangdong, Peoples R China
[3] Guangzhou Med Univ, Dept Pathol, Guangzhou Peoples Hosp 1, Guangzhou 510180, Guangdong, Peoples R China
[4] Guangzhou Med Univ, Clin Mol Med & Mol Diagnost Lab, Guangzhou Peoples Hosp 1, Guangzhou 510180, Guangdong, Peoples R China
[5] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA
关键词
Human colon cancer; Multidrug resistance; 5-Fluorouracil; Recombinant adenovirus-mediated p53; Xenografts in nude mice; TUMOR-SUPPRESSOR GENE; COLORECTAL-CANCER; MULTIDRUG-RESISTANCE; THYMIDYLATE SYNTHASE; DRUG-RESISTANCE; BREAST-CANCER; CELL-LINE; 5-FLUOROURACIL; THERAPY; CARCINOMA;
D O I
10.3748/wjg.v22.i32.7342
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM To investigate the anticancer effect of a recom-binant adenovirus-mediated p53 (rAd-p53) combined with 5-fluorouracil (5-FU) in human colon cancer resistant to 5-FU in vivo and the mechanism of rAd-p53 in reversal of 5-FU resistance. METHODS Nude mice bearing human colon cancer SW480/5FU (5-FU resistant) were randomly assigned to four groups (n = 25 each): control group, 5-FU group, rAd-p53 group, and rAd-p53 + 5-FU group. At 24 h, 48 h, 72 h, 120 h and 168 h after treatment, 5 mice were randomly selected from each group and sacrificed using an overdose of anesthetics. The tumors were removed and the protein expressions of p53, protein kinase C (PKC), permeability-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) (Western blot) and apoptosis (TUNEL) were determined. RESULTS The area ratios of tumor cell apoptosis were larger in the rAd/p53 + 5-FU group than that in the control, 5-FU and rAd/p53 groups (P < 0.05), and were larger in the rAd/p53 group than that of the control group (P < 0.05) and the 5-FU group at more than 48 h (P < 0.05). The p53 expression was higher in the rAd/p53 and the rAd/p53 + 5-FU groups than that of the control and 5-FU groups (P < 0.05), and were higher in the rAd/p53 + 5-FU group than that of the rAd/p53 group (P < 0.05). Overexpression of PKC, P-gp and MRP1 was observed in the 5-FU and control groups. In the rAd/p53 + 5-FU group, the expression of P-gp and MRP1 was lower that of the control and 5-FU groups (P < 0.05), and the expression of PKC was lower than that of the control, 5-FU and rAd/p53 groups at more than 48 h (P < 0.05). In the rAd/p53 group, the expression of P-gp and MRP1 was lower that of the control and 5-FU groups at more than 48 h (P < 0.05), and the expression of PKC was lower than that of the control and 5-FU groups at more than 120 h (P < 0.05). CONCLUSION 5-FU combined with rAd-p53 has a synergistic anticancer effect in SW480/5-FU (5-FU resistance), which contributes to reversal 5-FU resistance.
引用
收藏
页码:7342 / 7352
页数:11
相关论文
共 50 条
  • [41] Synergistic anticancer effect of rAd/P53 combined with 5-fluorouracil or iodized oil in the early therapeutic response of human colon cancer in vivo
    Xie, Qi
    Liang, Bi-Ling
    Wu, Yan-Heng
    Zhang, Jing
    Chen, Ming-Wang
    Liu, Hong-Yan
    Gu, Xiong-Fei
    Xu, Jin
    GENE, 2012, 499 (02) : 303 - 308
  • [42] Enhancement of antitumor effects by the combination chemoradiotherapy with S-1, oxaliplatin on a 5-FU resistant human colon cancer xenografts
    Nakata, Eiko
    Fukushima, Masakazu
    Takai, Yoshihiro
    Nemoto, Kenji
    Ogawa, Yoshihiro
    Luka, Milas
    Yamada, Shogo
    CANCER RESEARCH, 2006, 66 (08)
  • [43] Autophagic cell death induced by 5-FU in Bax or PUMA deficient human colon cancer cell
    Xiong, Hai-yan
    Guo, Xian-ling
    Bu, Xin-xin
    Zhang, Shan-shan
    Ma, Nan-nan
    Song, Jian-rui
    Hu, Fei
    Tao, Shuang-fen
    Sun, Kai
    Li, Rong
    Wu, Meng-chao
    Wei, Li-xin
    CANCER LETTERS, 2010, 288 (01) : 68 - 74
  • [44] Inhibition of p53 increases chemosensitivity to 5-FU in nutrient-deprived hepatocarcinoma cells by suppressing autophagy
    Guo, Xian-ling
    Hu, Fei
    Zhang, Shan-shan
    Zhao, Qiu-dong
    Zong, Chen
    Ye, Fei
    Guo, Shi-wei
    Zhang, Jian-wei
    Li, Rong
    Wu, Meng-chao
    Wei, Li-xin
    CANCER LETTERS, 2014, 346 (02) : 278 - 284
  • [45] P53 expression predicts a positive clinical result following a 5-FU based chemotherapy program in advanced colorectal cancer
    Zaninelli, M
    Tomezzoli, A
    Piubello, Q
    Franceschi, T
    Sabbioni, R
    Cetto, GL
    Bonetti, A
    ANNALS OF ONCOLOGY, 2000, 11 : 76 - 76
  • [46] Inhibition of protein FAK enhances 5-FU chemosensitivity to gastric carcinoma via p53 signaling pathways
    Hou, Jingjing
    Tan, Yuyu
    Su, Chen
    Wang, Tao
    Gao, Zhixing
    Song, Dan
    Zhao, Jiabao
    Liao, Yueting
    Liu, Xiaotian
    Jiang, Ying
    Feng, Qian
    Wan, Zhong
    Yu, Yongsheng
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2020, 18 : 125 - 136
  • [47] Efficacy of nab-paclitaxel on 5-fluorouracil (5-FU) resistant human gastric cancer cell lines
    Nukatsuka, Mamoru
    Kobunai, Takashi
    Matsuoka, Kazuaki
    Takechi, Teiji
    CANCER RESEARCH, 2014, 74 (19)
  • [48] Gemcitabine and 5-FU disrupt nuclear transport and subsequent localization of p21, p27 and p53 in cancer cells
    Nickle, Audrey
    Resendes, Karen K.
    FASEB JOURNAL, 2018, 32 (01):
  • [49] Effect of resveratrol on the radiosensitivity of 5-FU in human breast cancer MCF-7 cells
    Aghamiri, Shahin
    Jafarpour, Ali
    Zandsalimi, Farshid
    Aghemiri, Mehran
    Shoja, Mohsen
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (09) : 15671 - 15677
  • [50] EFFECT OF HYPERBARIC-OXYGEN AND 5-FU ON THE GROWTH OF HUMAN COLONIC-CANCER CELLS
    MCMILLAN, LC
    ROSS, JAS
    WALLACE, HM
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 : P266 - P266